Search - tctmd.com

Displaying 801 - 820 of 1342

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Opinion CV Team Dispatch

October 2020 News Roundup

L.A. McKeown

October 01, 2020

News Daily News

ECMO Registry Data Show Progress in COVID-19

Caitlin E. Cox

October 01, 2020

News Daily News

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Daily News

Young Women With AMICS: High Risk, Inadequate Care

L.A. McKeown

September 29, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Shelley Wood

September 22, 2020

News Daily News

GARFIELD-AF: Wrong DOAC Dose Can Be Lethal in A-fib

Todd Neale

September 16, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Conference News

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

L.A. McKeown

September 10, 2020

News Conference News ESC 2020

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Shelley Wood

September 04, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Conference News ESC 2020

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Michael O'Riordan

September 04, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

Todd Neale

August 31, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Shelley Wood

August 31, 2020

News Conference News ESC 2020

More Than Half of Patients See a GP in the 2 Weeks Before OHCA

Yael L. Maxwell

August 28, 2020

News Daily News

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Michael O'Riordan

August 26, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for September 2020

October 2020 News Roundup

ECMO Registry Data Show Progress in COVID-19

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Young Women With AMICS: High Risk, Inadequate Care

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

GARFIELD-AF: Wrong DOAC Dose Can Be Lethal in A-fib

Renal Function Gains Seen in CKD Patients After TAVR

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Dapagliflozin Wins in Patients With CKD

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

More Than Half of Patients See a GP in the 2 Weeks Before OHCA

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content